FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041515026> ?p ?o ?g. }

• W3041515026 endingPage "2373" @default.
• W3041515026 startingPage "2364" @default.
• W3041515026 abstract "Background and Purpose: The comparative effectiveness of direct-acting oral anticoagulants, compared with warfarin, for risks of stroke/systemic embolism, major bleeding, or death have not been studied in Medicare beneficiaries with atrial fibrillation and nondialysis-dependent chronic kidney disease. Methods: Medicare data from 2011 to 2017 were used to identify patients with stages 3, 4, or 5 chronic kidney disease and new atrial fibrillation who received a new prescription for warfarin, apixaban, rivaroxaban, or dabigatran. We estimated marginal hazard ratios with 95% CIs for the association of each direct-acting oral anticoagulant, compared with warfarin, for the outcomes of interest using inverse-probability-of-treatment weighted Cox proportional hazards models in as-treated and intention-to-treat analyses. Results: A total of 22 739 individuals met criteria (46.3% warfarin, 29.6% apixaban, 17.2% rivaroxaban, 6.9% dabigatran). Across the groups of anticoagulant users, mean age was 78.4 to 79.0 years; 50.3% to 51.4% were women, and 80.3% to 82.8% had stage 3 chronic kidney disease. In the as-treated analysis, for stroke/systemic embolism, hazard ratios, all compared with warfarin, were 0.70 (0.51–0.96) for apixaban, 0.80 (0.54–1.17) for rivaroxaban, and 1.15 (0.69–1.94) for dabigatran. For major bleeding, analogous hazard ratios were 0.47 (0.37–0.59) for apixaban, 1.05 (0.85–1.30) for rivaroxaban, and 0.95 (0.70–1.31) for dabigatran. There was no difference in the risk of all-cause mortality between the direct-acting oral anticoagulants and warfarin. Results of the intention-to-treat analysis were similar. Conclusions: Apixaban, compared with warfarin, was associated with decreased risk of stroke/systemic embolism and major bleeding; risks for both outcomes with rivaroxaban and dabigatran did not differ from risks with warfarin." @default.
• W3041515026 created "2020-07-16" @default.
• W3041515026 creator A5009525675 @default.
• W3041515026 creator A5018610662 @default.
• W3041515026 creator A5039466089 @default.
• W3041515026 creator A5073092690 @default.
• W3041515026 creator A5074637684 @default.
• W3041515026 date "2020-08-01" @default.
• W3041515026 modified "2023-10-14" @default.
• W3041515026 title "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation" @default.
• W3041515026 cites W1834574045 @default.
• W3041515026 cites W2008557562 @default.
• W3041515026 cites W2026766534 @default.
• W3041515026 cites W2045221270 @default.
• W3041515026 cites W2061326496 @default.
• W3041515026 cites W2078346178 @default.
• W3041515026 cites W2079491969 @default.
• W3041515026 cites W2096246254 @default.
• W3041515026 cites W2097854437 @default.
• W3041515026 cites W2110818436 @default.
• W3041515026 cites W2116559262 @default.
• W3041515026 cites W2127211051 @default.
• W3041515026 cites W2127985968 @default.
• W3041515026 cites W2136489990 @default.
• W3041515026 cites W2148984742 @default.
• W3041515026 cites W2152412672 @default.
• W3041515026 cites W2155965977 @default.
• W3041515026 cites W2156377081 @default.
• W3041515026 cites W2162508946 @default.
• W3041515026 cites W2162586165 @default.
• W3041515026 cites W2319792245 @default.
• W3041515026 cites W2410330926 @default.
• W3041515026 cites W2435343268 @default.
• W3041515026 cites W2465663631 @default.
• W3041515026 cites W2472624475 @default.
• W3041515026 cites W2622276831 @default.
• W3041515026 cites W2742504245 @default.
• W3041515026 cites W2757693118 @default.
• W3041515026 cites W2771089314 @default.
• W3041515026 cites W2771175339 @default.
• W3041515026 cites W2783940129 @default.
• W3041515026 cites W2787578429 @default.
• W3041515026 cites W2789518760 @default.
• W3041515026 cites W2807204637 @default.
• W3041515026 cites W2820917509 @default.
• W3041515026 cites W2909049445 @default.
• W3041515026 cites W2911904731 @default.
• W3041515026 cites W2929067776 @default.
• W3041515026 cites W2946321184 @default.
• W3041515026 cites W2970895804 @default.
• W3041515026 cites W2979591584 @default.
• W3041515026 cites W2985219892 @default.
• W3041515026 cites W4205645630 @default.
• W3041515026 cites W4362054082 @default.
• W3041515026 doi "https://doi.org/10.1161/strokeaha.120.028934" @default.
• W3041515026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32640949" @default.
• W3041515026 hasPublicationYear "2020" @default.
• W3041515026 type Work @default.
• W3041515026 sameAs 3041515026 @default.
• W3041515026 citedByCount "29" @default.
• W3041515026 countsByYear W30415150262020 @default.
• W3041515026 countsByYear W30415150262021 @default.
• W3041515026 countsByYear W30415150262022 @default.
• W3041515026 countsByYear W30415150262023 @default.
• W3041515026 crossrefType "journal-article" @default.
• W3041515026 hasAuthorship W3041515026A5009525675 @default.
• W3041515026 hasAuthorship W3041515026A5018610662 @default.
• W3041515026 hasAuthorship W3041515026A5039466089 @default.
• W3041515026 hasAuthorship W3041515026A5073092690 @default.
• W3041515026 hasAuthorship W3041515026A5074637684 @default.
• W3041515026 hasBestOaLocation W30415150261 @default.
• W3041515026 hasConcept C126322002 @default.
• W3041515026 hasConcept C127413603 @default.
• W3041515026 hasConcept C164705383 @default.
• W3041515026 hasConcept C207103383 @default.
• W3041515026 hasConcept C2776301958 @default.
• W3041515026 hasConcept C2778205648 @default.
• W3041515026 hasConcept C2778653478 @default.
• W3041515026 hasConcept C2778661090 @default.
• W3041515026 hasConcept C2778810321 @default.
• W3041515026 hasConcept C2779161974 @default.
• W3041515026 hasConcept C2780638905 @default.
• W3041515026 hasConcept C2780645631 @default.
• W3041515026 hasConcept C44249647 @default.
• W3041515026 hasConcept C71924100 @default.
• W3041515026 hasConcept C78519656 @default.
• W3041515026 hasConceptScore W3041515026C126322002 @default.
• W3041515026 hasConceptScore W3041515026C127413603 @default.
• W3041515026 hasConceptScore W3041515026C164705383 @default.
• W3041515026 hasConceptScore W3041515026C207103383 @default.
• W3041515026 hasConceptScore W3041515026C2776301958 @default.
• W3041515026 hasConceptScore W3041515026C2778205648 @default.
• W3041515026 hasConceptScore W3041515026C2778653478 @default.
• W3041515026 hasConceptScore W3041515026C2778661090 @default.
• W3041515026 hasConceptScore W3041515026C2778810321 @default.
• W3041515026 hasConceptScore W3041515026C2779161974 @default.
• W3041515026 hasConceptScore W3041515026C2780638905 @default.
• W3041515026 hasConceptScore W3041515026C2780645631 @default.

• next